과제정보
This work was supported by the Bio Industrial Strategic Technology Development Program (20003883, 20005021) funded By the Ministry of Trade, Industry & Energy (MOTIE, Korea), and grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HR16C0001, HG22C0024).
참고문헌
- Stang PE, Ryan PB, Racoosin JA, et al. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med 2010;153:600-6.
- Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc 2012;19:54-60.
- Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015;216:574-8.
- Hripcsak G. OHDSI 2022 state of the community [Internet]. [place unknown]: Observational Health Data Sciences and Informatics; 2022 [cited 2022 October 23]. Available from: https://www.ohdsi.org/wp-content/uploads/2022/10/OHDSI2022-state-of-community-Hripcsak-FDA-Titans.pdf.
- Haendel MA, Chute CG, Robinson PN. Classification, ontology, and precision medicine. N Engl J Med 2018;379:1452-62.
- Seong Y, You SC, Ostropolets A, et al. Incorporation of Korean electronic data interchange vocabulary into observational medical outcomes partnership vocabulary. Healthc Inform Res 2021;27:29-38.
- Yoon D, Ahn EK, Park MY, et al. Conversion and data quality assessment of electronic health record data at a Korean tertiary teaching hospital to a common data model for distributed network research. Healthc Inform Res 2016;22:54-8.
- Blacketer C, Defalco FJ, Ryan PB, Rijnbeek PR. Increasing trust in real-world evidence through evaluation of observational data quality. J Am Med Inform Assoc 2021;28:2251-7.
- Hripcsak G, Ryan PB, Duke JD, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A 2016;113:7329-36.
- Kostka K, Duarte-Salles T, Prats-Uribe A, et al. Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS. Clin Epidemiol 2022;14:369-84.
- Brat GA, Weber GM, Gehlenborg N, et al. International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium. NPJ Digit Med 2020;3:109.
- You SC, Jung S, Swerdel JN, et al. Comparison of first-line dual combination treatments in hypertension: real-world evidence from multinational heterogeneous cohorts. Korean Circ J 2020;50:52-68.
- Suchard MA, Schuemie MJ, Krumholz HM, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet 2019;394:1816-26.
- Schuemie MJ, Ryan PB, Pratt N, et al. Principles of Large-scale Evidence Generation and Evaluation across a Network of Databases (LEGEND). J Am Med Inform Assoc 2020;27:1331-7.
- Chan You S, Krumholz HM, Suchard MA, et al. Comprehensive comparative effectiveness and safety of first-line β-blocker monotherapy in hypertensive patients: a large-scale multicenter observational study. Hypertension 2021;77:1528-38.
- You SC, Rho Y, Bikdeli B, et al. Association of ticagrelor vs clopidogrel with net adverse clinical events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. JAMA 2020;324:1640-50.
- Reps JM, Schuemie MJ, Suchard MA, Ryan PB, Rijnbeek PR. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc 2018;25:969-75.
- Rieke N, Hancox J, Li W, et al. The future of digital health with federated learning. NPJ Digit Med 2020;3:119.
- Dayan I, Roth HR, Zhong A, et al. Federated learning for predicting clinical outcomes in patients with COVID-19. Nat Med 2021;27:1735-43.
- Mamidi TK, Tran-Nguyen TK, Melvin RL, Worthey EA. Development of an individualized risk prediction model for COVID-19 using electronic health record data. Front Big Data 2021;4:675882.
- Tong J, Luo C, Islam MN, et al. Distributed learning for heterogeneous clinical data with application to integrating COVID-19 data across 230 sites. NPJ Digit Med 2022;5:76.
- Williams RD, Markus AF, Yang C, et al. Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network. BMC Med Res Methodol 2022;22:35.
- Nestsiarovich A, Reps JM, Matheny ME, et al. Predictors of diagnostic transition from major depressive disorder to bipolar disorder: a retrospective observational network study. Transl Psychiatry 2021;11:642.
- Jung H, Yoo S, Kim S, et al. Patient-Level fall risk prediction using the observational medical outcomes partnership's common data model: pilot feasibility study. JMIR Med Inform 2022;10:e35104.
- Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ 2010;340:c221.
- Cooper H, Patall EA. The relative benefits of meta-analysis conducted with individual participant data versus aggregated data. Psychol Methods 2009;14:165-76.
- Selmer R, Haglund B, Furu K, et al. Individual-based versus aggregate meta-analysis in multi-database studies of pregnancy outcomes: the Nordic example of selective serotonin reuptake inhibitors and venlafaxine in pregnancy. Pharmacoepidemiol Drug Saf 2016;25:1160-9.
- La Gamba F, Corrao G, Romio S, et al. Combining evidence from multiple electronic health care databases: performances of one-stage and two-stage meta-analysis in matched case-control studies. Pharmacoepidemiol Drug Saf 2017;26:1213-9.
- Schuemie MJ, Chen Y, Madigan D, Suchard MA. Combining cox regressions across a heterogeneous distributed research network facing small and zero counts. Stat Methods Med Res 2022;31:438-50.
- Marquis-Gravel G, Roe MT, Robertson HR, et al. Rationale and design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) trial. JAMA Cardiol 2020;5:598-607.